Renaissance Technologies LLC Buys 495,300 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST)

Renaissance Technologies LLC grew its stake in LifeStance Health Group, Inc. (NASDAQ:LFST) by 421.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 612,800 shares of the company’s stock after purchasing an additional 495,300 shares during the quarter. Renaissance Technologies LLC owned about 0.16% of LifeStance Health Group worth $4,516,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of LFST. Blue Trust Inc. lifted its holdings in LifeStance Health Group by 124.4% in the fourth quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock worth $27,000 after buying an additional 2,122 shares during the period. LPL Financial LLC grew its stake in LifeStance Health Group by 6.0% in the fourth quarter. LPL Financial LLC now owns 37,584 shares of the company’s stock worth $277,000 after purchasing an additional 2,127 shares during the period. Legal & General Group Plc raised its holdings in LifeStance Health Group by 4.6% in the fourth quarter. Legal & General Group Plc now owns 134,557 shares of the company’s stock worth $992,000 after purchasing an additional 5,917 shares in the last quarter. Rhumbline Advisers lifted its position in LifeStance Health Group by 4.5% during the fourth quarter. Rhumbline Advisers now owns 195,581 shares of the company’s stock valued at $1,441,000 after buying an additional 8,487 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of LifeStance Health Group by 0.8% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,113,499 shares of the company’s stock valued at $8,206,000 after buying an additional 9,046 shares in the last quarter. 85.50% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on LFST shares. Canaccord Genuity Group initiated coverage on shares of LifeStance Health Group in a research report on Thursday, April 3rd. They set a “buy” rating and a $8.00 price target for the company. KeyCorp assumed coverage on LifeStance Health Group in a research report on Tuesday, April 8th. They set an “overweight” rating and a $9.00 price objective for the company. Finally, William Blair reissued an “outperform” rating on shares of LifeStance Health Group in a research note on Friday, February 28th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $8.58.

Insider Activity at LifeStance Health Group

In other news, insider Lisa K. Miller sold 18,845 shares of the stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $6.90, for a total value of $130,030.50. Following the transaction, the insider now owns 339,810 shares in the company, valued at $2,344,689. This represents a 5.25 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 6.60% of the stock is owned by company insiders.

LifeStance Health Group Stock Performance

Shares of LFST stock opened at $6.16 on Tuesday. The firm has a market capitalization of $2.37 billion, a PE ratio of -23.69 and a beta of 1.30. The company has a 50 day moving average price of $7.12 and a 200-day moving average price of $7.32. LifeStance Health Group, Inc. has a 52 week low of $4.64 and a 52 week high of $8.61. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.